Try it
General Medicine · Endocrinology and diabetes: hypercalcaemia of malignancy treatment
Sample itemA 62-year-old man with squamous cell lung cancer has confusion, polyuria and dehydration. Serum calcium is 14.2 mg/dL, PTH is suppressed and PTHrP is raised. After starting intravenous isotonic saline, which drug gives the most durable reduction in calcium?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Zoledronic acid
Hypercalcaemia of malignancy is mainly caused by PTHrP-driven bone resorption. After rehydration, an intravenous bisphosphonate inhibits osteoclasts and lowers calcium over days for weeks. Calcitonin acts quickly but loses effect within a couple of days.
Option by option
A. Cinacalcet
Cinacalcet acts on the parathyroid calcium sensor, but PTH is already suppressed.
B. Salmon calcitonin
Calcitonin acts rapidly but its effect fades from tachyphylaxis.
C. Hydrochlorothiazide
Thiazides reduce urinary calcium excretion and would raise calcium further.
D. Zoledronic acid (correct)
Correct. Bisphosphonates give a sustained fall in calcium by inhibiting bone resorption.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More General Medicine questions
- EndocrinologyA 19-year-old with type 1 diabetes presents with vomiting, deep rapid breathing, fruity…
- ElectrolytesWhich is the earliest ECG change in hyperkalaemia?
- Infectious diseaseWhat is the drug of choice for Pneumocystis jirovecii pneumonia in a patient with advanc…
- NeurologyA chronic alcohol user is brought in confused, with nystagmus and an unsteady gait. What…